Form 8-K - Current report:
SEC Accession No. 0001493152-18-001103
Filing Date
2018-01-26
Accepted
2018-01-26 16:24:38
Documents
4
Period of Report
2018-01-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 53292
2 ex3-1.htm EX-3.1 9633
3 ex10-1.htm EX-10.1 78996
4 ex10-2.htm EX-10.2 111395
  Complete submission text file 0001493152-18-001103.txt   254883
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 18552184
SIC: 2834 Pharmaceutical Preparations